Results from a recent study suggest that adolescents with HIV who are treated at pediatric clinics are less likely to discontinue antiretroviral therapy than adolescents treated at adult clinics.
“Adolescence and young adulthood is a unique period characterized by developmental and psychosocial change,” said Dr. Allison Agwu, assistant professor of infectious diseases at Johns Hopkins University and lead author of the study.
“There must be careful consideration about what kinds of clinical sites may be best to provide care for this population,” she added.
The authors of the study speculated that lower patient-to-provider ratios, availability of youth-friendly programs to support treatment adherence, and an increased emphasis on social services and case management might underlie the lower discontinuation rates in pediatric clinics.
Complete article at Aids Beacon : http://bit.ly/uXK7lo